159 related articles for article (PubMed ID: 34534673)
1. Non-alkylator anti-glioblastoma agents induced cell cycle G2/M arrest and apoptosis: Design, in silico physicochemical and SAR studies of 2-aminoquinoline-3-carboxamides.
Yuan P; Gu X; Ni X; Qi Y; Shao X; Xu X; Liu J; Qian X
Bioorg Med Chem Lett; 2021 Nov; 51():128371. PubMed ID: 34534673
[TBL] [Abstract][Full Text] [Related]
2. 1-Oxoeudesm-11(13)-eno-12,8a-lactone induces G2/M arrest and apoptosis of human glioblastoma cells in vitro.
Liu SS; Wang YF; Ma LS; Zheng BB; Li L; Xie WD; Li X
Acta Pharmacol Sin; 2013 Feb; 34(2):271-81. PubMed ID: 23160341
[TBL] [Abstract][Full Text] [Related]
3. Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle.
Ren LW; Li W; Zheng XJ; Liu JY; Yang YH; Li S; Zhang S; Fu WQ; Xiao B; Wang JH; Du GH
Acta Pharmacol Sin; 2022 Jan; 43(1):194-208. PubMed ID: 34433903
[TBL] [Abstract][Full Text] [Related]
4. Decane-1,2-diol derivatives as potential antitumor agents for the treatment of glioblastoma.
Viswanathan A; Zhurina A; Assoah B; Paakkunainen A; Musa A; Kute D; Saravanan KM; Yli-Harja O; Candeias NR; Kandhavelu M
Eur J Pharmacol; 2018 Oct; 837():105-116. PubMed ID: 30179612
[TBL] [Abstract][Full Text] [Related]
5. Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition.
Gortany NK; Panahi G; Ghafari H; Shekari M; Ghazi-Khansari M
Cancer Chemother Pharmacol; 2021 Jun; 87(6):827-842. PubMed ID: 33688998
[TBL] [Abstract][Full Text] [Related]
6. Novel 9-Methylanthracene Derivatives as p53 Activators for the Treatment of Glioblastoma Multiforme.
Feng Y; Wang Y; Li X; Sun Z; Qiang S; Wang H; Liu Y
Molecules; 2024 May; 29(10):. PubMed ID: 38792257
[TBL] [Abstract][Full Text] [Related]
7. Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma.
Nepali K; Hsu TI; Hsieh CM; Lo WL; Lai MJ; Hsu KC; Lin TE; Chuang JY; Liou JP
Eur J Med Chem; 2021 May; 217():113338. PubMed ID: 33744690
[TBL] [Abstract][Full Text] [Related]
8. Novel piperazine based benzamide derivatives as potential anti-glioblastoma agents inhibiting cell proliferation and cell cycle progression.
Lu Y; Feng Y; Li Z; Li J; Zhang H; Hu X; Jiang W; Shi T; Wang Z
Eur J Med Chem; 2022 Jan; 227():113908. PubMed ID: 34656900
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway.
Szeliga M; Karpińska M; Rola R; Niewiadomy A
Bioorg Chem; 2020 Dec; 105():104362. PubMed ID: 33074121
[TBL] [Abstract][Full Text] [Related]
10. Deglucohellebrin: A Potent Agent for Glioblastoma Treatment.
Vartholomatos E; Alexiou GA; Markopoulos GS; Lazari D; Tsiftsoglou O; Chousidis I; Leonardos I; Kyritsis AP
Anticancer Agents Med Chem; 2020; 20(1):103-110. PubMed ID: 31755397
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and cytotoxicity of novel 2-arylvinyl-4-aminoquinoline derivatives.
Jiang N; Zhai X; Chen Z; Liang C; Sun C; Han J; Gong P
Chem Pharm Bull (Tokyo); 2012; 60(5):659-64. PubMed ID: 22689404
[TBL] [Abstract][Full Text] [Related]
12. Identification of imidazo[4,5-c]pyridin-2-one derivatives as novel Src family kinase inhibitors against glioblastoma.
Zhang L; Yang Z; Sang H; Jiang Y; Zhou M; Huang C; Huang C; Wu X; Zhang T; Zhang X; Wan S; Zhang J
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1541-1552. PubMed ID: 34238111
[TBL] [Abstract][Full Text] [Related]
13. Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma.
Bronner SM; Merrick KA; Murray J; Salphati L; Moffat JG; Pang J; Sneeringer CJ; Dompe N; Cyr P; Purkey H; Boenig GL; Li J; Kolesnikov A; Larouche-Gauthier R; Lai KW; Shen X; Aubert-Nicol S; Chen YC; Cheong J; Crawford JJ; Hafner M; Haghshenas P; Jakalian A; Leclerc JP; Lim NK; O'Brien T; Plise EG; Shalan H; Sturino C; Wai J; Xiao Y; Yin J; Zhao L; Gould S; Olivero A; Heffron TP
Bioorg Med Chem Lett; 2019 Aug; 29(16):2294-2301. PubMed ID: 31307887
[TBL] [Abstract][Full Text] [Related]
14. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
15. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
16. A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis.
Wang H; Zheng J; Xu W; Chen C; Wei D; Ni W; Pan Y
Molecules; 2017 Sep; 22(10):. PubMed ID: 28961210
[TBL] [Abstract][Full Text] [Related]
17. Antitumoral Activity of the Universal Methyl Donor
Mosca L; Pagano C; Tranchese RV; Grillo R; Cadoni F; Navarra G; Coppola L; Pagano M; Mele L; Cacciapuoti G; Laezza C; Porcelli M
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675528
[TBL] [Abstract][Full Text] [Related]
18. N-(p-coumaroyl) serotonin inhibits glioblastoma cells growth through triggering S-phase arrest and apoptosis.
Lazari D; Alexiou GA; Markopoulos GS; Vartholomatos E; Hodaj E; Chousidis I; Leonardos I; Galani V; Kyritsis AP
J Neurooncol; 2017 May; 132(3):373-381. PubMed ID: 28365838
[TBL] [Abstract][Full Text] [Related]
19. Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines.
Harvey KA; Xu Z; Saaddatzadeh MR; Wang H; Pollok K; Cohen-Gadol AA; Siddiqui RA
J Neurosurg; 2015 Mar; 122(3):547-56. PubMed ID: 25526274
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of
Majkowska-Pilip A; Rius M; Bruchertseifer F; Apostolidis C; Weis M; Bonelli M; Laurenza M; Królicki L; Morgenstern A
Chem Biol Drug Des; 2018 Jul; 92(1):1344-1356. PubMed ID: 29611298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
